New data indicates that retatrutide, a dual-action medication, may represent a major step in weight management. This drug combines the effects of a GLP-1 receptor and a GIP agonist , potentially offering a greater impact than available solutions. Clinical assessments have demonstrated positive results , including substantial decreases in size a… Read More